Comparison between LGT Business Connextions IPO and Mahamaya Lifesciences IPO.
LGT Business Connextions IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Mahamaya Lifesciences IPO is a SME Bookbuilding proposed to list at BSE SME.
| LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Mark Corporate Advisors Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of LGT Business Connextions IPO is up to ₹26.68 Cr whereas the issue size of the Mahamaya Lifesciences IPO is up to ₹66.91 Cr. The final issue price of LGT Business Connextions IPO is ₹107.00 per share and of Mahamaya Lifesciences IPO is ₹114.00 per share.
| LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹108.00 per share | |
| Issue Price (Upper) | ₹114.00 per share | |
| Issue Price (Final) | ₹107.00 per share | ₹114.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 22,30,800 shares | 53,29,200 shares |
| Fresh Issue Size (Amount) | up to ₹23.87 Cr | up to ₹60.75 Cr |
| OFS Issue Size | 2,62,800 shares | 5,40,000 shares |
| OFS Issue Size (Amount) | up to ₹2.81 Cr | up to ₹6.16 Cr |
| Issue Size Total | 24,93,600 shares | 58,69,200 shares |
| Issue Size Total (Amount) | up to ₹26.68 Cr | up to ₹66.91 Cr |
LGT Business Connextions IPO opens on Aug 19, 2025, while Mahamaya Lifesciences IPO opens on Nov 11, 2025. The closing date of LGT Business Connextions IPO and Mahamaya Lifesciences IPO is Aug 21, 2025, and Nov 13, 2025, respectively.
| LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
|---|---|---|
| Anchor Bid Date | Nov 10, 2025 | |
| Issue Open | Aug 19, 2025 | Nov 11, 2025 |
| Issue Close | Aug 21, 2025 | Nov 13, 2025 |
| Basis Of Allotment (Tentative) | Aug 22, 2025 | Nov 14, 2025 |
| Initiation of Refunds (Tentative) | Aug 25, 2025 | Nov 17, 2025 |
| Credit of Share (Tentative) | Aug 25, 2025 | Nov 17, 2025 |
| Listing date (Tentative) | Aug 26, 2025 | Nov 18, 2025 |
| Anchor Lockin End date 1 | Dec 13, 2025 | |
| Anchor Lockin End date 2 | Feb 11, 2026 |
LGT Business Connextions IPO P/E ratio is 14.38, as compared to Mahamaya Lifesciences IPO P/E ratio of 15.65.
| LGT Business Connextions IPO | Mahamaya Lifesciences IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)LGT Business Connextions Ltd.'s revenue increased by 13% and profit after tax (PAT) rose by 44% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Mahamaya Lifesciences Ltd.'s revenue increased by 64% and profit after tax (PAT) rose by 148% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.95 | 77.27 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.95 | 56.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.38 | 15.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹100.29 Cr. | ₹266.82 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 41.89% | 34.94% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.19% | 23.15% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.77 | 1.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.44 | ₹7.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 41.89% | 26.19% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the LGT Business Connextions IPO Retail Individual Investors (RII) are offered 12,46,800 shares while in Mahamaya Lifesciences IPO retail investors are offered 12,46,800 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in LGT Business Connextions IPO and 11,76,000 shares in Mahamaya Lifesciences IPO.
| LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,52,000 shares | |
| Market Maker Reservation | 1,32,000 shares | 3,09,600 shares |
| QIB | 0 shares | 11,76,000 shares |
| NII | 12,46,800 shares | 8,82,000 shares |
| RII | 12,46,800 shares | 20,59,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 24,93,600 shares | 58,69,200 shares |
LGT Business Connextions IPO subscribed 1.25x in total, whereas Mahamaya Lifesciences IPO subscribed 1.63x.
| LGT Business Connextions IPO | Mahamaya Lifesciences IPO | |
|---|---|---|
| QIB (times) | 1.19x | |
| NII (times) | 0.75x | 3.63x |
| Big NII (times) | 5.00x | |
| Small NII (times) | 0.90x | |
| RII (times) | 1.75x | 1.02x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.25x | 1.63x |
